Tibet Duo Rui Pharmaceutical Co.Ltd(301075) independent director nominee statement
The nominee Tibet Duo Rui Pharmaceutical Co.Ltd(301075) board of Directors hereby makes a public statement on nominating Mr. Wang Yunguo as the candidate for independent director of Tibet Duo Rui Pharmaceutical Co.Ltd(301075) first board of directors. The nominee has agreed in writing to be an independent director candidate of Tibet Duo Rui Pharmaceutical Co.Ltd(301075) the first board of directors. This nomination is made after fully understanding the nominee’s occupation, educational background, professional qualification, detailed work experience and all part-time jobs. The nominee believes that the nominee meets the requirements of relevant laws, administrative regulations, departmental rules, normative documents and business rules of Shenzhen Stock Exchange on the qualification and independence of independent director candidates. The specific statements are as follows: 1 The nominee is not allowed to serve as a director of the company in accordance with Article 146 of the company law of the people’s Republic of China. □ yes □ no if no, please specify in detail: II. The nominee meets the qualifications and conditions of independent directors specified in the rules for independent directors of listed companies of the CSRC. □ yes □ no if not, please specify in detail: III. the nominee meets the conditions for holding the office of independent director specified in the articles of association. □ yes □ no if not, please specify: IV. the nominee has participated in the training and obtained relevant certificates recognized by the stock exchange. □ yes □ no if not, please specify in detail: the nominee has not obtained the qualification certificate of independent director, and has made a written commitment to participate in the latest independent director training and obtain the qualification certificate of independent director recognized by Shenzhen Stock Exchange.
5、 The appointment of the nominee as an independent director will not violate the relevant provisions of the civil servant law of the people’s Republic of China. □ yes □ no if not, please specify: VI. the nominee’s appointment as an independent director will not violate the relevant provisions of the notice on regulating the resignation of middle management cadres from public office or serving as independent directors and independent supervisors of listed companies and fund management companies after retirement (retirement) issued by the Central Commission for Discipline Inspection of the Communist Party of China. □ yes □ no if not, please specify: VII. The nominee’s appointment as an independent director will not violate the relevant provisions of the opinions on further regulating the part-time (tenure) of Party and government leading cadres in enterprises issued by the Organization Department of the CPC Central Committee. □ yes □ no if not, please specify in detail: VIII. The appointment of the nominee as an independent director will not violate the relevant provisions of the opinions on strengthening the anti-corruption construction of colleges and universities issued by the CPC Central Commission for Discipline Inspection, the Ministry of education and the Ministry of supervision. □ yes □ no if not, please specify: IX. the nominee’s appointment as an independent director will not violate the relevant provisions of the guidelines on the system of independent directors and external supervisors of joint-stock commercial banks issued by the people’s Bank of China. □ yes □ no
10、 The appointment of the nominee as an independent director will not violate the relevant provisions of the measures for the supervision of the qualifications of directors, supervisors and senior managers of securities companies of the CSRC. □ yes □ no if not, please specify in detail: Xi. The nominee’s appointment as an independent director will not violate the relevant provisions of the measures for the administration of the qualifications of directors (directors) and senior managers of banking financial institutions of the China Banking and Insurance Regulatory Commission. □ yes □ no if not, please specify in detail: XII. The nominee’s appointment as an independent director will not violate the relevant provisions of the administrative provisions on the qualifications of directors, supervisors and senior managers of insurance companies and the administrative measures for independent directors of insurance institutions issued by the China Banking and Insurance Regulatory Commission. □ yes □ no if no, please specify: XIII. The nominee’s appointment as an independent director will not violate other laws, administrative regulations, departmental rules, normative documents and business rules of Shenzhen Stock Exchange. □ yes □ no if no, please specify: XIV. The nominee has basic knowledge related to the operation of listed companies, is familiar with relevant laws, administrative regulations, departmental rules, normative documents and business rules of Shenzhen Stock Exchange, and has more than five years of working experience necessary to perform the duties of independent directors. □ yes □ no 15. The nominees, their immediate family members and their main social relations do not work in the company and its subsidiaries. □ yes □ no if no, please specify: XVI. The nominee and his immediate family members are not shareholders who directly or indirectly hold more than 1% of the issued shares of the company, nor are they natural person shareholders among the top ten shareholders of the listed company. □ yes □ no if no, please specify: 17. The nominee and his immediate family members do not work in the shareholder units that directly or indirectly hold more than 5% of the issued shares of the company, nor in the top five shareholder units of the listed company. □ yes □ no if no, please explain in detail: XVIII. The nominee and his immediate family members do not work in the controlling shareholder, actual controller and affiliated enterprises of the company. □ yes □ no if no, please specify: 19. The nominee is not a person who provides financial, legal, consulting and other services for the company, its controlling shareholders, actual controllers or their respective subsidiaries. □ yes □ no if not, please specify: 20. The nominee does not work in the unit with significant business dealings with the company and its controlling shareholders, actual controllers or their respective subsidiaries, nor in the controlling shareholder unit with significant business dealings.
□ yes □ No: Please specify any of the circumstances listed in the last 12 months □ No. □ yes □ no if not, please explain in detail: 22. The nominee is not a person who has been banned from entering the securities market by the CSRC and whose term has not expired. □ yes □ no if not, please specify: 23. The nominee is not a person publicly recognized by the stock exchange as unfit to serve as a director, supervisor and senior manager of a listed company, and the term has not expired. □ yes □ no if not, please specify in detail: 24. The nominee is not a person who has been subject to criminal punishment by the judicial organ or administrative punishment by the CSRC for securities and Futures Crimes in the last 36 months. □ yes □ no if not, please explain in detail: 25. The nominee has not been publicly condemned or criticized by the stock exchange for more than three times in the past 36 months. □ yes □ no if not, please specify in detail: XXVI. The nominee has not been recognized and restricted by the national development and Reform Commission and other ministries and commissions to serve as a director of a listed company because he is the object of punishment for dishonesty. □ yes □ no if no, please specify: XXVII. The nominee is not an independent director in the past. During the period of not attending the board meeting in person for three consecutive times, or failing to attend the board meeting in person for two consecutive times and not entrusting other directors to attend the board meeting, he is proposed by the board of directors to be replaced by the general meeting of shareholders for less than 12 months. □ yes □ no if no, please specify: XXVIII. Including the company, the number of listed companies with nominees concurrently serving as independent directors shall not exceed 5. □ yes □ no if not, please specify: 29. The nominee has served as an independent director in the company for no more than six years. □ yes □ no if not, please explain in detail: 30. The nominee has urged the board of directors to publicize the nominee’s occupation, education, professional qualifications, detailed work experience, all part-time jobs and other details in accordance with the requirements of the guidelines for self discipline supervision of listed companies No. 2 – Guidelines for standardized operation of companies listed on GEM (hereinafter referred to as the guidelines for standardized operation of GEM). □ yes □ no if no, please explain in detail: 31. During the past period of serving as an independent director, the nominee did not personally attend the board meeting of the listed company for two consecutive times. □ yes □ no if no, please specify: 32. During the past period of serving as an independent director, the nominee did not personally attend the board meeting of the listed company for 12 consecutive months, which exceeded half of the total number of board meetings during the period.
□ yes □ no if not, please explain in detail: 33. During the past period when the nominee served as an independent director, there was no case that the independent director’s opinion was not expressed as required or the independent opinion was proved to be obviously inconsistent with the facts. □ yes □ no if not, please specify: 34. The nominee has not been punished by other relevant departments other than the CSRC in the last 36 months. □ yes □ no if no, please specify:
□ yes □ no if not, please explain in detail: 36. The nominee is not removed by the listed company before the expiration of the term of office of the independent director in the past. □ yes □ no if not, please specify: 37. The nominee has no other circumstances that affect the integrity and diligence of independent directors. □ yes □ no if no, please specify:
The declarant solemnly declares that:
The nominee warrants that the above statement is true, accurate and complete without false records, misleading statements or major omissions; Otherwise, the nominee is willing to bear the legal liability arising therefrom and accept the self-discipline supervision measures or disciplinary sanctions of Shenzhen Stock Exchange.
The nominee authorizes the Secretary of the board of directors of the company to enter and submit the contents of this statement to the Shenzhen Stock Exchange or make an announcement through the gem business area of Shenzhen Stock Exchange. The above acts of the Secretary of the board of directors are deemed to be the acts of the nominee, and the nominee shall bear corresponding legal liabilities.
Nominee (seal): Tibet Duo Rui Pharmaceutical Co.Ltd(301075) board of directors March 23, 2022
